Provided by Tiger Trade Technology Pte. Ltd.

REVVITY INC

152.06
-1.5400-1.00%
Volume:1.08M
Turnover:161.39M
Market Cap:17.00B
PE:72.61
High:152.49
Open:152.33
Low:146.83
Close:153.60
52wk High:166.25
52wk Low:81.22
Shares:111.80M
Float Shares:102.00M
Volume Ratio:0.54
T/O Rate:1.06%
Dividend:0.28
Dividend Rate:0.18%
EPS(TTM):2.09
EPS(LYR):2.07
ROE:3.21%
ROA:2.37%
PB:2.35
PE(LYR):73.50

Loading ...

Revvity Q1 FY26 income from continuing operations slips 2% to $40.9 million; revenue rises 7% to $711.1 million

Reuters
·
May 13

Revvity (RVTY) Receives a Hold from Guggenheim

TIPRANKS
·
May 12

Revvity Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
May 12

Is Revvity (RVTY) Offering Value After Recent Share Price Strength?

Simply Wall St.
·
May 11

Revvity Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 09

Revvity releases transcript of first-quarter 2026 earnings call

Reuters
·
May 08

Revvity Is Maintained at Equal-Weight by Barclays

Dow Jones
·
May 08

Revvity Inc. Stock Climbs 7.4%, Outperforms Peers

Dow Jones
·
May 07

Revvity Inc. Stock Advances 6.7%, Outperforms Peers

Dow Jones
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel

Reuters
·
May 06

BUZZ-Revvity rises after first-quarter profit beat

Reuters
·
May 05

Stock Track | Revvity Soars 6.24% Intraday on Strong Q1 Earnings Beat and Strategic China Business Divestiture

Stock Track
·
May 05

Revvity Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Revvity Exec Says Seasonal Uptick Seen From Q1 to Q2; Margins Expected to Rise to About 29% in Q3 - Conf Call

THOMSON REUTERS
·
May 05

Revvity Exec Says China Diagnostics Demand, Pricing Hit by Policy Headwinds - Conf Call

THOMSON REUTERS
·
May 05

Revvity Exec Says Co Plans to Remain Prudent With Its Forward-Looking Assumptions - Conf Call

THOMSON REUTERS
·
May 05

Revvity Exec Says Co's Immuno-Diagnostics Business Declined in the Low Single Digits Organically in Q1 - Conf Call

THOMSON REUTERS
·
May 05

Revvity Exec Says Co Expects Q2 Organic Growth to Be in the Range of 2% to 3% - Conf Call

THOMSON REUTERS
·
May 05

Revvity Exec Says Co Exepcts a Continuation, IF Not Acceleration, of Life Sciences Performance in Chine Through 2026 - Conf Call

THOMSON REUTERS
·
May 05

Revvity Exec Says Co Saw Positive Growth From Pharma and Academic Customer for the First Time Since Q2 2023 - Conf Call

THOMSON REUTERS
·
May 05